Celgene (CELG) Inventory Turnover Ratio, from third quarter 2019 to third quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Celgene Corp  (NASDAQ: CELG)
 

Celgene Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Celgene Corp inventory turnover ratio, the Celgene Corp's ability to sell and replace its inventory in the third quarter 2019, sequentially increased to 1.38 in the third quarter 2019, yet the ratio remained below the average, as CELG's market remain challenging.Average inventory processing period, for the Celgene in Sep 30 2019 quarter, has decreased to 264 days, compare to 277 days, in the Jun 30 2019 quarter.

Within Healthcare sector 325 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1891 in the second quarter 2019, to 1896.

CELG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Celgene Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELG Inventory Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Inventory Growth -11.57 % -16.4 % -17.54 % -15.34 % -5.03 %
Y / Y Cost of Sales Growth 6.37 % 19.84 % 3.7 % 42.02 % 33.05 %
Inventory Turnover Ratio (TTM) 1.38 1.32 1.21 1.14 1
CELG's Total Ranking # 1896 # 1891 # 1894 # 1891 # 2029
Average inventory processing period 264 277 303 320 364
Seq. Inventory Growth -2.8 % 4.98 % -3.49 % -10.2 % -8.11 %
Seq. Cost of Sales Growth 10.6 % 7.86 % -17.16 % 7.64 % 24.6 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 108
Healthcare Sector # 326
Overall Market # 1896

Inventory Turnover Ratio Statistics
High Average Low
6.31 1.93 0.87
(June 30. 2006)   (Jun 30 2017)



CELG Company Profile >> Back to CELG Efficiency Comparisons >> Compare CELG Inventory Turnover Ratio to its Competitors

Financial Statements
Celgene's Inventories $ 451 Millions Visit CELG's Balance sheet
Celgene's Cost of Revenues TTM $ 627 Millions Visit CELG's Income Statement
What are CELG's Sales? Visit CELG's Sales by Segment

Other Inventory Turnover Ratios
Celgene's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CELG's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CELG's Competitors
Inventory Turnover Ratio for CELG's Suppliers
Inventory Turnover Ratio for CELG's Customers

You may also want to know
CELG's Sales Growth Rates CELG's Pe Price to earnings ratio CELG's Receivables Turnover Ratio CELG's Stock Quote
CELG's Net Income Growth Rates CELG's Ps Price to Sales ratio CELG's Sales per Employee CELG's Asset Turnover Ratio
CELG's Net Margin CELG's Pb Price to Book ratio CELG's Financial Strength Ratios CELG's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2019 Inventories at quarter ending Sep 30 2019
Reliv International Inc  3.82 $ 9.821  Millions$ 3  Millions
Verastem Inc   3.80 $ 1.334  Millions$ 0  Millions
Bausch Health Companies Inc   3.79 $ 2,244.000  Millions$ 592  Millions
Gw Pharmaceuticals Plc  3.79 $ 21.730  Millions$ 6  Millions
Baxter International Inc   3.78 $ 6,504.000  Millions$ 1,719  Millions
Enovis Corp  3.71 $ 2,115.242  Millions$ 570  Millions
Standard Biotools Inc   3.71 $ 51.926  Millions$ 14  Millions
Luna Innovations Inc  3.67 $ 33.229  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.64 $ 9,534.000  Millions$ 2,617  Millions
Mettler toledo International Inc   3.62 $ 1,010.758  Millions$ 280  Millions
Novocure Limited  3.60 $ 86.848  Millions$ 24  Millions
Catheter Precision Inc   3.60 $ 8.300  Millions$ 2  Millions
Inspire Medical Systems inc   3.60 $ 12.597  Millions$ 4  Millions
Agilent Technologies inc   3.58 $ 2,358.000  Millions$ 659  Millions
Retractable Technologies Inc  3.58 $ 25.744  Millions$ 7  Millions
Aptevo Therapeutics Inc   3.55 $ 18.253  Millions$ 5  Millions
Remedent Inc   3.55 $ 0.409  Millions$ 0  Millions
Cambrex Corp  3.54 $ 402.273  Millions$ 114  Millions
Becton Dickinson And Company  3.50 $ 9,002.000  Millions$ 2,572  Millions
Strata Skin Sciences Inc  3.49 $ 11.436  Millions$ 3  Millions
Atrion Corporation  3.48 $ 121.218  Millions$ 35  Millions
Cantel Medical Corp   3.48 $ 511.738  Millions$ 147  Millions
Allied Healthcare Products inc   3.47 $ 26.669  Millions$ 8  Millions
Tearlab Corp  3.43 $ 8.510  Millions$ 2  Millions
Hologic Inc  3.43 $ 1,520.300  Millions$ 444  Millions
Innovage Holding Corp   3.43 $ 6.934  Millions$ 2  Millions
Vertex Pharmaceuticals Inc  3.43 $ 485.035  Millions$ 142  Millions
Precision Optics Corporation Inc   3.40 $ 5.126  Millions$ 2  Millions
Quanterix Corporation  3.39 $ 26.515  Millions$ 8  Millions
Veru Inc   3.36 $ 10.147  Millions$ 3  Millions

Date modified: 2026-09-08T15:09:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.